HHS announces drug pricing reform leadership change
John O’Brien will soon depart his position as senior advisor for drug pricing reform, Health and Human Services Secretary Alex Azar announced yesterday. John Brooks, principal deputy director of the Center for Medicare, will expand his current responsibilities to fill the vacancy. O’Brien, a pharmacist who previously served as deputy assistant secretary for health policy, assumed the senior advisor role last December and helped design and execute President Trump’s blueprint to lower prescription drug prices.
Related News Articles
Headline
Health and Human Services Secretary Xavier Becerra Jan. 8 appointed as chief competition officer Stacy Sanders, who currently oversees the department's…
Headline
President Biden intends to appoint as the next Centers for Disease Control and Prevention director Mandy Cohen, M.D., who served as secretary of the North…
Headline
The Government Accountability Office May 26 announced the appointment of five new members to the Medicare Payment Advisory Commission, along with two…
News
The AHA today sent letters to leaders of the Senate Committee on Health, Education, Labor and Pensions and the Senate Committee on Finance expressing the…
Headline
Brad Smith, former chief operating officer for Anthem’s Diversified Business Group, will serve as director of the Center for Medicare & Medicaid Innovation…
Headline
The Senate today voted 72-18 to confirm Stephen Hahn, M.D., as Food and Drug Administration commissioner. Hahn currently serves as chief medical executive and…